Expression analysis of miR-223 in plasma of patients with non-small cell lung cancer and other obstructive lung diseases

D. Marinova (Sofia, Bulgaria), D. Kachakova (Sofia, Bulgaria), D. Dimitrova (Sofia, Bulgaria), A. Lilov (Sofia, Bulgaria), E. Mekov (Sofia, Bulgaria), M. Mihailov (Sofia, Bulgaria), S. Giragosyan (Sofia, Bulgaria), Y. Slavova (Sofia, Bulgaria), D. Kostadinov (Sofia, Bulgaria), V. Youroukova (Sofia, Bulgaria), R. Petkov (Sofia, Bulgaria), A. Mitkova (Sofia, Bulgaria), R. Kaneva (Sofia, Bulgaria), V. Mitev (Sofia, Bulgaria)

Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Session: Lung cancer: novel prognostic markers and scores
Session type: Thematic Poster
Number: 2795

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Marinova (Sofia, Bulgaria), D. Kachakova (Sofia, Bulgaria), D. Dimitrova (Sofia, Bulgaria), A. Lilov (Sofia, Bulgaria), E. Mekov (Sofia, Bulgaria), M. Mihailov (Sofia, Bulgaria), S. Giragosyan (Sofia, Bulgaria), Y. Slavova (Sofia, Bulgaria), D. Kostadinov (Sofia, Bulgaria), V. Youroukova (Sofia, Bulgaria), R. Petkov (Sofia, Bulgaria), A. Mitkova (Sofia, Bulgaria), R. Kaneva (Sofia, Bulgaria), V. Mitev (Sofia, Bulgaria). Expression analysis of miR-223 in plasma of patients with non-small cell lung cancer and other obstructive lung diseases. 2795

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Non-small cell lung cancer resected molecular expression in COPD and low function pulmonary patients
Source: Annual Congress 2007 - Biology, diagnosis and rare tumours in thoracic malignancies
Year: 2007


A modified ILD-GAP index for patients with non-small cell lung cancer and interstitial lung disease
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018



Clinicopathologic features of patients with non-small cell lung cancer and chronic obstructive pulmonary disease undergoing lung cancer surgery
Source: Virtual Congress 2020 – Localised non-small cell lung cancer
Year: 2020


Tumour infiltrating lymphocytes and tumour associated macrophages in chronic obstructive pulmonary disease (COPD) patients with non-small cell lung cancer (NSCLC) and in patients with NSCLC
Source: Eur Respir J 2005; 26: Suppl. 49, 92s
Year: 2005

Evaluation expression of miR-146a and miR-155 and inflammatory  cytokines in blood of non-small cell lung cancer patients
Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research
Year: 2021


Importance of clusterin expression at tissue level for the prognosis of non-small cells lung cancer
Source: Annual Congress 2009 - Lung cancer biology
Year: 2009


Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival
Source: Eur Respir J 2011; 37: 617-623
Year: 2011



Comparing exhaled molecular profiles of patients with non-small cell lung cancer (NSCLC) with those of patients with non-pulmonary malignancy
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010

Survivin expression in non-small cell lung cancer
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases
Year: 2010

Role of EBUS-TBNA in the study of PD-L1 expression in patients with non-small cell lung cancer (NSCLC)
Source: Virtual Congress 2020 – Endobronchial ultrasound: from rookie to pro
Year: 2020


Coexistence of chronic obstructive pulmonary disease in patients with advanced non-small cell lung cancer and impact on survival
Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Year: 2017


Gene expression profiles in non-small cell lung cancer (NSCLC) and lung tissue in smokers and non-smokers
Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer
Year: 2009


Gene expression analysis in patients with non-small cell lung cancer subjected to thoracotomy
Source: Annual Congress 2009 - Genetics in the smokers corner: from inflammation in smokers via COPD to cancer
Year: 2009


Does the lung function affect the survival time in patients with resected non-small cell lung cancer?
Source: Annual Congress 2007 - Lung function parameters before and after thoracic surgery
Year: 2007


Changes of lung function in patients with non-small cell lung cancer tretaed by chemotherapy
Source: Eur Respir J 2006; 28: Suppl. 50, 771s
Year: 2006

Management of brain metastases in patients with non-small cell lung cancer
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017


Choice of endogenous control for gene expression in nonsmall cell lung cancer
Source: Eur Respir J 2005; 26: 1002-1008
Year: 2005



Advanced non-small cell lung cancer in elderly patients
Source: Breathe 2012; 9: 26-34
Year: 2012

Investigation of survivin gene polymorphism in non-small cell lung cancer patients (NSCLC)
Source: Annual Congress 2012 - New biomarkers for lung cancer
Year: 2012


Two-stage treatment of non-small cell lung cancer (NSCLC) in patients with severe coronary heart disease.
Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology
Year: 2019